Simulations Plus 경영진

경영진 기준 점검 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

핵심 정보

Shawn O'Connor

최고경영자

US$1.7m

총 보수

CEO 급여 비율	30.86%
CEO 재임 기간	less than a year
CEO 지분 보유율	n/a
경영진 평균 재임 기간	less than a year
이사회 평균 재임 기간	4.7yrs

최근 경영진 업데이트

Recent updates

Simulations Plus, Inc. (NASDAQ:SLP) Shares Could Be 44% Below Their Intrinsic Value Estimate

Oct 28

The Bottom Fishing Club - Simulations Plus: Huge Potential In AI Drug Discovery

Sep 22

Some Simulations Plus, Inc. (NASDAQ:SLP) Shareholders Look For Exit As Shares Take 25% Pounding

Jul 31

Simulations Plus, Inc.'s (NASDAQ:SLP) Stock Retreats 36% But Earnings Haven't Escaped The Attention Of Investors

Jun 13

Are Investors Undervaluing Simulations Plus, Inc. (NASDAQ:SLP) By 28%?

May 07

Simulations Plus: Benefiting From FDA Modernization And AI

Apr 16

Simulations Plus, Inc.'s (NASDAQ:SLP) 25% Jump Shows Its Popularity With Investors

Apr 13

Why Investors Shouldn't Be Surprised By Simulations Plus, Inc.'s (NASDAQ:SLP) 29% Share Price Surge

Feb 08

Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal

Jan 08

We Think Simulations Plus' (NASDAQ:SLP) Healthy Earnings Might Be Conservative

Nov 07

Biosimulation Innovations And Tactical Acquisitions To Boost Drug Development Growth

Oct 27 Integration and expansion into new markets drive revenue growth and improved profitability through increased efficiencies and enhanced offerings.

Simulations Plus: Questionable Whether It Will Benefit Or Be Hurt By Generative AI

Feb 01

We Like Simulations Plus' (NASDAQ:SLP) Earnings For More Than Just Statutory Profit

Jan 12

Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal

Nov 06

CEO 보수 분석

Shawn O'Connor의 보수는 Simulations Plus의 수익에 비해 어떻게 변했나요?
날짜	총 보수	급여	회사 수익
May 31 2025	n/a	n/a	-US$63m
Feb 28 2025	n/a	n/a	US$7m
Nov 30 2024	n/a	n/a	US$8m
Aug 31 2024	US$2m	US$512k	US$10m
May 31 2024	n/a	n/a	US$10m
Feb 29 2024	n/a	n/a	US$11m
Nov 30 2023	n/a	n/a	US$11m
Aug 31 2023	US$2m	US$487k	US$10m
May 31 2023	n/a	n/a	US$10m
Feb 28 2023	n/a	n/a	US$10m
Nov 30 2022	n/a	n/a	US$11m
Aug 31 2022	US$1m	US$450k	US$12m
May 31 2022	n/a	n/a	US$12m
Feb 28 2022	n/a	n/a	US$12m
Nov 30 2021	n/a	n/a	US$10m
Aug 31 2021	US$1m	US$444k	US$10m
May 31 2021	n/a	n/a	US$12m
Feb 28 2021	n/a	n/a	US$11m
Nov 30 2020	n/a	n/a	US$10m
Aug 31 2020	US$739k	US$350k	US$9m
May 31 2020	n/a	n/a	US$9m
Feb 29 2020	n/a	n/a	US$9m
Nov 30 2019	n/a	n/a	US$9m
Aug 31 2019	US$425k	US$325k	US$9m

보상 대 시장: Shawn의 총 보수(USD1.66M)는 US 시장에서 비슷한 규모 기업의 평균(USD2.29M) 수준입니다.

보상과 수익: Shawn의 보상은 지난 1년 동안 회사 실적과 일치했습니다.

CEO

Shawn O'Connor (65 yo)

less than a year

재임 기간

US$1,657,620

보수

Mr. Shawn M. O'Connor serves as Chief Executive Officer of Simulations Plus, Inc. since 2025 and had been Chief Executive Officer since June 26, 2018 until 2025. Mr. O'Connor joined Simulations Plus, Inc....

리더십 팀

이름	직위	재임 기간	보수	지분
Shawn O'Connor	Chief Executive Officer	less than a year	US$1.66m	데이터 없음
William Frederick	EVP & CFO	4.9yrs	US$1.01m	0.010% $ 36.3k
John DiBella	Chief Revenue Officer	less than a year	US$661.62k	0.40% $ 1.4m
Josh Fohey	Chief Operating Officer	less than a year	데이터 없음	데이터 없음
Jennifer Presnell	Accounting Manager	no data	데이터 없음	데이터 없음
Bud Nelson	VP of Corporate Counsel & Personal Data Protection Officer	no data	데이터 없음	데이터 없음
Tanya Marvin	Marketing Manager	1.1yrs	데이터 없음	데이터 없음
Lindsay Luke	Vice President of Human Resources	3.8yrs	데이터 없음	데이터 없음
Jonathan Chauvin	Co-Chief of Product & Technology Officer	less than a year	데이터 없음	데이터 없음
Sandra Suarez Sharp	Global Head of Regulatory Strategies	less than a year	데이터 없음	데이터 없음
Grant Fowler	Senior VP of Engineering - Adaptive Learning & Insights	1.8yrs	데이터 없음	데이터 없음
Brad Stefanovic	Head of Clinical Innovation - Adaptive Learning & Insights	no data	데이터 없음	데이터 없음

0.8yrs

평균 재임 기간

53yo

평균 나이

경험이 풍부한 관리: SLP의 경영진은 경험이 부족한 것으로 간주됩니다(평균 재임 0.8 년) — 신규 팀일 수 있습니다.

이사회 구성원

이름	직위	재임 기간	보수	지분
Walter Woltosz	Director	29.4yrs	US$200.07k	16.34% $ 56.8m
Daniel Weiner	Independent Chairman of the Board	8.5yrs	US$210.07k	0.063% $ 218.8k
Lisa LaVange	Independent Director	6.5yrs	US$190.07k	0.054% $ 187.3k
Ravindra Mehta	Member of Scientific Advisory Board	4.7yrs	데이터 없음	데이터 없음
Paul Watkins	Chairman of Scientific Advisory Board	4.7yrs	데이터 없음	데이터 없음
John Paglia	Independent Director	10.9yrs	US$200.07k	0.053% $ 184.9k
Frank Sistare	Member of Scientific Advisory Board	4.7yrs	데이터 없음	데이터 없음
Lauren Aleksunes	Member of Scientific Advisory Board	4.7yrs	데이터 없음	데이터 없음
K. Hallow	Member of Scientific Advisory Board	4.7yrs	데이터 없음	데이터 없음
Sharlene Evans	Independent Director	3.9yrs	US$187.57k	0.066% $ 229.6k

4.7yrs

평균 재임 기간

71yo

평균 나이

경험이 풍부한 이사회: SLP의 이사회는 경험이 있음으로 간주됩니다(평균 재임 4.7 년).

기업 분석 및 재무 데이터 상태

데이터	최종 업데이트 (UTC 시간)
기업 분석	2025/11/28 17:13
종가	2025/11/26 00:00
수익	2025/05/31
연간 수익	2024/08/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
기업 재무제표	10년	손익계산서 현금흐름표 대차대조표	SEC 양식 10-K SEC 양식 10-Q
분석가 컨센서스 추정치	+3년	재무 예측 분석가 목표주가	분석가 리서치 보고서 Blue Matrix
시장 가격	30년	주가 배당, 분할 및 기타 조치	ICE 시장 데이터 SEC 양식 S-1
지분 구조	10년	주요 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
경영진	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발	10년	회사 공시	SEC 양식 8-K

^* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 Github 페이지에서 확인할 수 있으며, 보고서 활용 방법에 대한 가이드와 Youtube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Simulations Plus, Inc.는 11명의 분석가가 다루고 있습니다. 이 중 7명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가	기관
David Larsen	BTIG
Dane Leone	CGS International
Constantine Davides	Citizens JMP Securities, LLC

Simulations Plus 경영진

경영진 기준 점검 3/4

핵심 정보

최근 경영진 업데이트

Director notifies of intention to sell stock

Director notifies of intention to sell stock

Insufficient new directors

Simulations Plus, Inc., Annual General Meeting, Feb 13, 2025

Simulations Plus, Inc. Announces Executive Changes, Effective August 30, 2024

lead Independent Director notifies of intention to sell stock

Recent updates

Simulations Plus, Inc. (NASDAQ:SLP) Shares Could Be 44% Below Their Intrinsic Value Estimate

Simulations Plus, Inc. to Report Q4, 2025 Results on Dec 01, 2025

Director notifies of intention to sell stock

The Bottom Fishing Club - Simulations Plus: Huge Potential In AI Drug Discovery

Some Simulations Plus, Inc. (NASDAQ:SLP) Shareholders Look For Exit As Shares Take 25% Pounding

Simulations Plus, Inc. and Institute of Medical Biology of the Polish Academy of Sciences Partnership Announces Results in Validation of ADMET Predictor Models with Enhanced AI Drug Design

Third quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

Simulations Plus, Inc. Updates Earnings Guidance for the Fiscal Year 2025

Consensus EPS estimates fall by 16%

Director notifies of intention to sell stock

Investor sentiment deteriorates as stock falls 33%

Consensus EPS estimates fall by 20%

Simulations Plus, Inc.'s (NASDAQ:SLP) Stock Retreats 36% But Earnings Haven't Escaped The Attention Of Investors

New minor risk - Share price stability

Now 34% undervalued after recent price drop

Simulations Plus, Inc. Provides Revenue Guidance for the Third Quarter and Full Year of Fiscal 2025

Simulations Plus, Inc. Releases ADMET Predictor 13

Investor sentiment deteriorates as stock falls 20%

Now 21% undervalued

Simulations Plus, Inc. Releases DILIsym 11

Are Investors Undervaluing Simulations Plus, Inc. (NASDAQ:SLP) By 28%?

Now 28% undervalued after recent price drop

Price target increased by 9.4% to US$46.60

Simulations Plus, Inc. Supports New FDA Roadmap for Reducing Animal Testing in Preclinical Safety Studies

Simulations Plus: Benefiting From FDA Modernization And AI

Simulations Plus, Inc.'s (NASDAQ:SLP) 25% Jump Shows Its Popularity With Investors

Second quarter 2025 earnings: EPS and revenues exceed analyst expectations

Simulations Plus, Inc. Provides Earnings Guidance for the Year 2025

Simulations Plus, Inc. to Report Q2, 2025 Results on Apr 03, 2025

Investor sentiment deteriorates as stock falls 15%

Why Investors Shouldn't Be Surprised By Simulations Plus, Inc.'s (NASDAQ:SLP) 29% Share Price Surge

Now 21% undervalued

Consensus EPS estimates fall by 38%

First quarter 2025 earnings: EPS misses analyst expectations

Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal

Simulations Plus, Inc. Provides Earnings Guidance for the Fiscal 2025

Insufficient new directors

Simulations Plus, Inc., Annual General Meeting, Feb 13, 2025

Simulations Plus, Inc. to Report Q1, 2025 Results on Jan 07, 2025

Investor sentiment improves as stock rises 16%

Simulations Plus, Inc. and University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables

We Think Simulations Plus' (NASDAQ:SLP) Healthy Earnings Might Be Conservative

Investor sentiment deteriorates as stock falls 16%

Biosimulation Innovations And Tactical Acquisitions To Boost Drug Development Growth

Price target decreased by 7.5% to US$52.75

Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Simulations Plus, Inc. Provides Earnings Guidance for Fiscal Year 2025

Simulations Plus, Inc. to Report Q4, 2024 Results on Oct 23, 2024

Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings

Simulations Plus, Inc. Announces Executive Changes, Effective August 30, 2024

Simulations Plus: Declining Margins Are A Problem

Now 21% undervalued after recent price drop

Simulations Plus, Inc. Releases the latest version of its quantitative systems toxicology (QST) platform, DILIsym version X

Upcoming dividend of US$0.06 per share

Simulations Plus: Steady Growth, But What About The Margins?

Consensus EPS estimates fall by 14%

Third quarter dividend of US$0.06 announced

Third quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Simulations Plus, Inc. Updates Earnings Guidance for the Fiscal 2024

Now 12% overvalued after recent price rise

Now 21% overvalued after recent price rise

Simulations Plus, Inc. to Report Q3, 2024 Results on Jul 02, 2024

Consensus EPS estimates fall by 17%, revenue upgraded

Price target increased by 12% to US$60.33

Simulations Plus, Inc. (NasdaqGS:SLP) acquired Pro-ficiency, LLC from NovaQuest Capital Management, L.L.C., QHP Capital, L.P. and Pro-ficiency’s minority shareholders for approximately $100 million.

Simulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software

Simulations Plus: Reliance On Consulting And Acquisitions Creates Doubts

lead Independent Director notifies of intention to sell stock

Upcoming dividend of US$0.06 per share